This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

US ex parte reexamination denial may signal end to post-IPR patent challenges

By Nick Robertson ( May 27, 2026, 14:33 GMT | Comment) -- The shift from inter partes review (IPR) to ex parte reexamination (EPR) at the US Patent and Trademark Office may become more difficult for patent challengers who have already pursued IPR unsuccessfully. A patent examiner Friday denied EPR on discretionary grounds, bringing settled expectations to EPR practice for what is believed to be the first time.The denial of a request for ex parte reexamination (EPR) at the US Patent and Trademark Office Friday on discretionary grounds signals the increased potential for the office's broad discretion over the institution of post-grant patent challenges to impact EPR practice....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents